Every rating change, initiation and price-target move the sell side published across the equities tracked here, newest first.
Ratings are attributed to the research firm, not to individual analysts. Latest event 2d ago.
| Ticker | Firm | Action | Rating | Target | Date |
|---|---|---|---|---|---|
| TXG10x Genomics, Inc. | Argus Research | Initiated | Buy | $110 | Sep 28 |
Showing the 1 most recent actions.